CSM Advisors’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.07M Buy
1,076,275
+49,819
+5% +$376K 0.13% 177
2026
Q2
$10.7M Buy
1,026,456
+168,944
+20% +$1.89M 0.23% 106
2026
Q1
$10.2M Buy
857,512
+76,164
+10% +$779K 0.25% 98
2025
Q4
$7.78M Buy
781,348
+39,013
+5% +$373K 0.21% 101
2025
Q3
$6.64M Buy
742,335
+90,258
+14% +$836K 0.19% 126
2025
Q2
$6.15M Buy
+652,077
New +$5.75M 0.18% 141

Other funds holding AHCO

CSM Advisors's AHCO Position: Q3 2026 in Review

CSM Advisors increased its AdaptHealth (AHCO) stake by 4.9% in Q3 2026, buying an estimated $376K and bringing the position to 1,076,275 shares worth $6.07M. The position accounts for 0.13% of the portfolio, ranked #177.

CSM Advisors first reported a position in AHCO in Q2 2025 and has held it in 6 quarters since. The position peaked at $10.7M in Q2 2026. 185 funds tracked by Wall St. Rank hold AHCO as of Q3 2026.

  • CSM Advisors held 1,076,275 shares of AdaptHealth worth $6.07M as of Q3 2026.
  • CSM Advisors bought 49,819 AdaptHealth shares in Q3 2026, an estimated $376K.
  • AdaptHealth made up 0.13% of CSM Advisors's portfolio in Q3 2026, its #177 holding.
  • CSM Advisors first reported a position in AdaptHealth in Q2 2025 and has held it in 6 quarters since.
  • CSM Advisors's AdaptHealth position peaked at $10.7M in Q2 2026.
  • 185 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2026.

Based on CSM Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.